LDR will be combined with the existing Spine & CMF group. It will be led by Adam Johnson, who is the Zimmer Biomet Group President, Spine, CMF and Thoracic and Dental. Zimmer is paying $37 per share for LDR, representing a steep 64% premium on the company's share price the day prior to the deal announcement. It will finance the purchase using cash on hand and a revolving credit facility. On the close of the deal, it will issue $750 million in senior unsecured notes to repay the credit facility to continue its ongoing moves to deleverage. - here is the announcement